Skip to main content
Fig. 3 | Journal of Ovarian Research

Fig. 3

From: RETRACTED ARTICLE: ANGPTL4 functions as an oncogene through regulation of the ETV5/CDH5/AKT/MMP9 axis to promote angiogenesis in ovarian cancer

Fig. 3

Promotion of OC cell progression by incubation with exogeneous cANGPTL4 protein. A Treatment with 250 ng/ml rhANGPTL4 increased SKOV3 and HO8910 cell migration compared with that in the PBS group, as shown by Transwell assays. Scale bars, 100 μm. B Treatment with 250 ng/ml rhANGPTL4 increased SKOV3 and HO8910 cell migration compared with that in the PBS group, as shown by wound healing assays. Scale bars, 400 μm. C Treatment with 250 ng/ml rhANGPTL4 increased SKOV3 and HO8910 cell invasion compared with that in the PBS group, as shown by Transwell assays. Scale bars, 100 μm

Back to article page